, 387(3), 205-216.Dauparas, J., et al. (2022). Robust deep learning–based protein sequence design using ProteinMPNN. Science, 378(6615), 49-56.
AI revolutionizes GLP-1 drugs: De novo design yields ultra-long-acting agonists beyond semaglutide, enabling monthly injections for obesity treatment.
Ailurus Bio is a pioneering company building biological programs, genetic instructions that act as living software to orchestrate biology. We develop foundational DNAs and libraries, transforming lab-grown cells into living instruments that streamline complex research and production workflows. We empower scientists and developers worldwide with these bioprograms, accelerating discovery and diverse applications. Our mission is to make biology the truly general-purpose technology, as programmable and accessible as modern computers, by constructing a biocomputer architecture for all.
.jpeg)
.jpeg)
.jpeg)